Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies (Q81223393)
Jump to navigation
Jump to search
scientific article published on 01 September 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies |
scientific article published on 01 September 2005 |
Statements
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies (English)
Guillermo Garcia-Manero
Maher Albitar
Susan M O'Brien
Jorge Cortes
Francis J Giles
Steven Kornblau
William Wierda
Hagop M Kantarjian
Karen W L Yee
Anne Hagey
Stefan Faderl
Deborah Thomas
Alessandra Ferrajoli
Evelyn McKeegan
David R Grimm
Toby Mueller
Rhonda R Holley-Shanks
Leonardo Sahelijo